Ahmann,Andrew

Institution: Oregon Health and Science University, USA

Research Interests: Affects, Aid, Best Practices, Chronic Disease, Clinical Research, Comparative Effectiveness Research, Cost, Cost Savings, Costs, Disease, Drugs, Evaluation, Glp-1, Glucagon, Glucagon-like Peptide-1, Head, Health, Healthcare, Healthcare Reform, Incretin